ANGELA CHEVES: Open Payments
NPI 1013560655 · NORTH LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 70 payments from 12 companies in 2025. Trend: 2023 $1,259 · 2024 $1,251 · 2025 $1,364
Food & beverage: $1,364
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $230 |
| Alnylam Pharmaceuticals Inc. | 7 | $203 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $201 |
| Novartis Pharmaceuticals Corporation | 14 | $163 |
| AstraZeneca Pharmaceuticals LP | 4 | $145 |
| Merck Sharp & Dohme LLC | 7 | $122 |
| Actelion Pharmaceuticals US, Inc. | 4 | $70 |
| Innovation Technologies Inc | 2 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
Products named: VYNDAQEL, AMVUTTRA, Kerendia, LEQVIO, VERQUVO, WAINUA, IRRISEPT, UPTRAVI.
Industry payments across AR — which companies pay providers there.
